Islet cell manufacturing is a research field and technological approach focused on the *in vitro* generation of functional insulin-producing cells, often derived from pluripotent stem cells, for therapeutic application. It investigates robust methods for controlled differentiation, purification, and scalable, clinical-grade production of these cells, holding significant promise for treating diseases such as type 1 diabetes by providing a potentially inexhaustible source of transplantable tissue.